Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: A pilot cross-sectional study

Patient Preference and Adherence

Volumn 7, Issue , 2013, Pages 891-895

  Ndiaye, Maimouna ^a,b   Nyasulu, Peter ^a   Nguyen, Hoang ^f,g   Lowenthal, Elizabeth D ^h,i   Gross, Robert ^h   Mills, Edward J ^c   Nachega, Jean B ^d,e,f  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Department of HIV AIDS Prevention and Care   (Botswana)

^c UNIVERSITY OF OTTAWA   (Canada)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g Hanoi Health Department   (Viet Nam)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Adolescents; ART adherence; Barriers; Botswana; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE;

ADOLESCENT; ARTICLE; BOTSWANA; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PILOT STUDY; RISK FACTOR; SEX DIFFERENCE; STRUCTURED QUESTIONNAIRE;

EID: 84884379158     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S47628     Document Type: Article

References (24)

1. UNAIDS report on the global AIDS epidemic 2012:42-56. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf. Accessed July 12, 2013.
2. Botswana Country Report, 2010. Progress report of the national response to 2001 declaration of commitment on HIV&AIDS. from: http://data.unaids.org/pub/Report/2010/botswana_2010_country_progress_report_en.pdf. Accessed July 12, 2013.
3. Baleta A. Botswana reduces mother-to-child transmission of HIV. Lancet. 2010;375(9730):1954.
4. Abadia-Barrero CE, Castro A. Experience of stigma and access to ART in children and adolescent living with HIV/AIDS in Brazil. Soc Sci Med. 2006;62(5):1219-1288.
5. Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR; Adolescent Medicine HIV/AIDS Research Network. Barriers to ART adherence among human immunodeficiency virus infected adolescents. Arch Pediatr Adolescent Med. 157:249-255.
6. Reisner SL, Mimiaga JM, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIV infected Youth. Top HIV Med. 2009;17(1):14-25.
7. Polisset J, Ametonou F, Elise A, Arrive E, Aho A, Perez F. Correlates of adherence to anti-retroviral therapy in HIV-Infected children in Lomé, Togo, West Africa. AIDS Behav. 2009;13:23-32.
8. Williams LP, Storm D, Montepiedra G, et al; PACTG 219C Team. Predictors of Adherence to Antiretroviral Medications in Children and Adolescents with HIV Infections. Pediatrics. 2006;118: e1745-e1757.
9. Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51(1):65-71.
10. Evans D, Menezes C, Mahomed K, et al. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Research and Human Retroviruses. 2013;29(6):892-900.
11. Nglazi MD, Kranzer K, Holele P, et al. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. BMC Infect Dis. 2012;12:21. Available online at http://www.biomedcentral.com/1471-2334/12/21. Accessed July 12, 2013.
12. Shroufi A, Gunguwo H, Dixon M, et al. HIV-infected adolescents in Southern Africa can achieve good treatment outcomes: Results from a retrospective cohort study. AIDS. March 21, 2013. [Epub ahead of print.].
13. Sawyer SM, Drew S, Yeo MS, Britto MT. Adolescents with a chronic condition: challenges living, challenges treating. Lancet. 2007;369: 1481-1489.
14. Spector SA, Hsia K, Yong FH, et al. Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children. J Infect Dis. 2000;182(6):1769-1773.
15. World Health Organization Web site. Informed consent template for research involving children (quantitative studies). http://www.who.int/rpc/research_ethics/informed_consent/en/.
16. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255-266.
17. University of Pittsburgh. Calculating adherence percentage. Research Coordinator Orientation. 2002. http://www.clinicalresearch.pitt.edu/docs/adherence_calculator.pdf. Accessed July 12, 2013.
18. Bakanda C, Birungi J, Mwesigwa R, et al. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PLoS One. 2011;6:e19261.
19. Lowenthal ED, Ellenberg JH, Machine E, et al. Association between efavirenz-based antiretroviral regimens and virologic failure in HIV-infected children. JAMA. 2013;309(17):1803-1809.
20. Braitstein P, Boulle A, Nash D, et al; Antiretroviral Therapy in Lower Income Countries (ART-LINC) study group. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt). 2008;17(1): 47-55.
21. Druyts E, Dybul M, Kanters S, et al. Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis. AIDS. 2013;27(3):417-425.
22. Oyugi JH, Byakika-Tusiime J, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007;21(8): 965-971.
23. Nachega JB, Mills EJ, Schechter M. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS. 2010;5(1):70-77.
24. Dowshen N, Kuhns LM, Gray C, Lee S, Garofalo R. Feasibility of interactive text message response (ITR) as a novel, real-time measure of adherence to antiretroviral therapy for HIV+ youth. AIDS Behav. 2013;17(6):2237-2243.